NCT07395531

Brief Summary

Dopaminergic medications and Deep Brain Stimulation (DBS) are the current standards interventions for Parkinson's Disease. Pharmacotherapy with dopaminergic drugs leads to partial improvement in motor functions of patients. Invasive therapies like DBS have as yet limited availability and accessibility, with risk of adverse events as well. Non invasive therapies like Transcranial Direct Current Stimulation (tDCS) are currently increasingly being probed for their therapeutic value, in view of their safety, portability and convenience of administration. Improvement in motor function immediately after a single session of tDCS has been observed. The effect of single simulation is not sustained beyond a few days. Only few studies with varied sites of stimulation have evaluated the effect of repetitive tDCS on motor function improvement in patients with Parkinson's Disease, with conflicting results. There is an unmet need to probe the utility of repetitive tDCS on motor function of patients with Parkinson's Disease. We aim to probe the effect of repetitive tDCS of dorsolateral prefrontal cortex and M1 cortex on motor function in patients with Parkinson's Disease (Hoehn and Yahr stage 2 to 4).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Feb 2026

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 25, 2026

Completed
7 days until next milestone

Study Start

First participant enrolled

February 1, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 9, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Completed
Last Updated

February 9, 2026

Status Verified

February 1, 2026

Enrollment Period

5 months

First QC Date

January 25, 2026

Last Update Submit

February 1, 2026

Conditions

Keywords

tDCSParkinson's DiseaseTranscranial Direct Current Stimulation

Outcome Measures

Primary Outcomes (1)

  • To determine change in motor function score as assessed by Movement Disorder Society - Unified Parkinson's Disease Rating Scale Part - III scale 1 week after the repetitive tDCS (Minimum Score 0, Maximum Score 132, higher scores indicate more disability)

    1 week

Secondary Outcomes (1)

  • To determine the change in Timed Up and Go test score of patients with Parkinson's Disease at 1 week after the repetitive tDCS (higher times indicate disability with increased risk of fall)

    1 week

Study Arms (2)

Anodal tDCS arm (will receive true tDCS)

EXPERIMENTAL

Will receive true anodal tDCS stimulation

Device: Transcranial Direct Current Stimulation

Sham tDCS arm (will receive Sham stimulation)

SHAM COMPARATOR

Will not receive anodal tDCS stimulation

Device: Transcranial Direct Current Stimulation

Interventions

Anodal tDCS stimulation

Also known as: tDCS
Anodal tDCS arm (will receive true tDCS)

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients fulfilling the Movement Disorder Society (MDS) clinical diagnostic criteria for Parkinson's disease.
  • Patients with Hoehn \& Yahr stages 2-4 Parkinson's disease.
  • Patients maintained on stable medical regimen for at least 1 month before entering the study.

You may not qualify if:

  • Patients with other confounding neurological and psychiatric disorders.
  • The presence of metal objects or stimulators in the head.
  • Patients with a history of deep brain stimulation.
  • Patients with history of seizures.
  • Patients with skull defect due to surgery e.g. craniectomy
  • Patients with scalp condition likely to obstruct application of electrodes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital

New Delhi, 110001, India

Location

MeSH Terms

Conditions

Parkinson Disease

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Ashish Kumar Duggal, DM (Neurology)

    Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, New Delhi

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ashish Kumar Duggal, Doctor (Professor)

CONTACT

Devavrata Sahu, Doctor

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Department of Neurology, ABVIMS and Dr RML Hospital, New Delhi

Study Record Dates

First Submitted

January 25, 2026

First Posted

February 9, 2026

Study Start

February 1, 2026

Primary Completion

June 30, 2026

Study Completion

July 31, 2026

Last Updated

February 9, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

IPD collected throughout the trial will be available from the Principle Investigator upon reasonable request.

Shared Documents
STUDY PROTOCOL, SAP, ICF

Locations